Immune checkpoint‑targeted cancer immunotherapies
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue
Abstract
Tumor cells may express on their surface various characteristic antigens that can induce antitumor immunity. However, cancer in human body may induce an immunosuppressive microenvironment that limits immune response to its antigens. For many years scientists have tried to develop an immunotherapy which would induce a potent antitumor immune response and lead to an elimination of the disease. One of the most promising immunotherapies is blockade of immune checkpoints, i.e. a group of costimulatory molecules negatively regulating the immune system. Their blockade would overcome immune tolerance in the tumor microenvironment and amplify antitumor immunity. What’s more, immune checkpoint blockade may turn out even more profitable, as some of immune checkpoints and their ligands are expressed on tumor surface and on tumor infiltrating lymphocytes, contributing to the immunosuppressive cancer microenvironment. Phase III clinical trials have confirmed efficacy of an anti‑CTLA‑4 antibody ipilimumab, thereby leading to its acceptance for the treatment of advanced melanoma. Thanks to promising results of the phase I clinical trials, a breakthrough therapy designation and an early approval for the treatment have been granted to anti‑PD‑1 antibodies ‑ nivolumab (for the treatment of advanced melanoma and advanced non‑small cell lung cancer) and pembrolizumab (for the treatment of advanced melanoma) and, in the treatment of advanced bladder cancer, an anti‑PD‑L1 antibody ‑ MPDL3280A as well. Other immune checkpoints, such as LAG‑3, TIM‑3, BTLA, B7‑H3 and B7‑H4, are also under early evaluation.
Authors and Affiliations
Julian Swatler, Ewa Kozłowska
Keywords
Related Articles
- EP ID EP220715
- DOI -
- Views 140
- Downloads 0
Phospholipids and products of their hydrolysis as dietary preventive factors for civilization diseases
The results of numerous epidemiological studies indicate that phospholipids play an important role in the prevention of chronic diseases faced by contemporary society. Firstly, these compounds are responsible for the pro...
Udział receptorów TLR w procesach autoimmunologicznych*
Receptory TLR (Toll like receptors) występują u wielu gatunków kręgowców i bezkręgowców. Odgrywają one istotną rolę w aktywacji komórek odpowiedzi immunologicznej nieswoistej, a także pośrednio swoistej. Rozpoznają różno...
Preliminary study on application of urine amino acids profiling for monitoring of renal tubular injury using GLC-MS
The early diagnosis of the nephrotoxic effect of xenobiotics and drugs is still an unsolved problem. Recent studies suggest a correlation between the nephrotoxic activity of xenobiotics and increased concentration of ami...
Polymorphism of CD36 gene, carbohydrate metabolism and plasma CD36 concentration in obese children. A preliminary study
Introduction: CD36 may play an important role in removal of oxidized LDLs from plasma, protein glycation, the pathogenesis of insulin resistance, type 2 diabetes, and diabetic micro- and macroangiopathy. Some reports hav...
Użyteczność przezkroczowej i przezodbytniczej ultrasonografii w diagnostyce i różnicowaniu zapalenia gruczołów apokrynowych z przetoką odbytu
Wstęp: Patogeneza zapalenia gruczołów apokrynowych nie jest dobrze poznana. Jest wiele teorii, w tym teorie mechaniczne, teorie podkreślające czynnik genetyczny, oraz teorie immunologiczne biorące pod uwagę dysfunkcje li...